Ashton Thomas Private Wealth’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
Ashton Thomas Private Wealth's BIB Position: Q3 2026 in Review
Ashton Thomas Private Wealth held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q3 2026 at 373 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1438.
Ashton Thomas Private Wealth first reported a position in BIB in Q2 2024 and has held it in 4 quarters since. 17 funds tracked by Wall St. Rank hold BIB as of Q3 2026.
- Ashton Thomas Private Wealth held 373 shares of ProShares Ultra NASDAQ Biotechnology worth $43.1K as of Q3 2026.
- Ashton Thomas Private Wealth left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q3 2026.
- ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #1438 holding.
- Ashton Thomas Private Wealth first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2024 and has held it in 4 quarters since.
- 17 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.